RecruitingNCT06467474

Psychoeducational Group for Depression

This study is recruiting. It focuses on depression and currently lists participation information in Brazil.

DepressionDrugFrom 18 Years to 59 Years

Need help deciding?

Ask HopeStage to review this study with me

Study reference: NCT06467474. HopeStage can help you review the study, but cannot decide medical eligibility.

In plain English

Key information made simple

This study is looking at whether psychoeducation can help people with depression (depression. Participants take part in psychoeducation and complete follow-up assessments. Some participants may receive Control Group instead of the study treatment, and direct benefit is not guaranteed.

What to expect

Your next step

The official record suggests in-person participation through a university, with sites including Institute of Psychiatry - Faculty of Medicine from University of Sao Paulo. Participation appears to involve guided sessions or support activities with check-ins on how they fit into daily life. The main fit is usually matching the main diagnosis and being able to understand the study and consent. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.

Before joining

Questions to ask before joining

What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?

Study clarity

Things to check before joining

Study start dateStarted: March 1, 2024

Time commitment: multiple visits or assessments
Study phase: Not available
Enrollment: Not available
Recruitment status: Recruiting
Sponsor: Ricardo Alberto Moreno, M.D., Ph.D.
Sponsor type: Unknown or unclear
Main activity: medication or study treatment
Intervention: Not available
Source: Official registry link

Want help reviewing this study?

Public study data

Key study information

Official title: Psychoeducational Group for Depression
Condition: Depression
Study status: Recruiting
Sponsor / lead affiliation: Ricardo Alberto Moreno, M.D., Ph.D.
Location / country: Brazil
Registry: ClinicalTrials.gov
External trial ID: NCT06467474

Why this study may matter

This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.

In practice

For you

Taking part may give access to a new approach being evaluated.

It requires regular follow-up, often through questionnaires or interviews.

Requires travel, with in-person participation in Brazil.

Official source

Registry reference

This page links back to the public source record so people can verify details directly with the registry and research team.

If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.

Official title: Psychoeducational Group for Depression
Source: ClinicalTrials.gov
Official registry link: Open official registry
External trial ID: NCT06467474

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is Psychoeducational Group for Depression?

This study is exploring medication or study treatment for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. It includes a comparison with a control group. Direct benefit is not guaranteed.

Who is behind this study, and what type of sponsor is it?

This study is sponsored by Ricardo Alberto Moreno, M.D., Ph.D.. We could not clearly classify the sponsor type from the available data. Check the official source record to verify who is responsible for the study.

What does participation involve, what phase is it, and what should I ask about safety?

This study may involve medication or study treatment, study visits, and assessments. The time commitment is multiple visits or assessments. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.

Where can I verify the study details?

Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me